Thioridazine in the Management of Geriatric Patients

Abstract

A five‐week study of thioridazine therapy was made in 14 geriatric patients with arteriosclerotic or “senile” disorders. The initial dosage was 75 mg daily, increased by 25 mg daily at weekly intervals. Mental alertness was preserved and no side‐effects were noted, in contrast results with some of the tranquilizers previously used by the patients. Tranquilizers have an important role in the management of geriatric patients. Thioridazine seems particularly suited for use in senile agitated states, for the control of symptoms while carrying out a positive programme of rehabilitation.